Skip to main content
Erschienen in: Neurological Sciences 4/2011

01.08.2011 | Review Article

Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients

verfasst von: Sara Bonazza, Chiara La Morgia, Paolo Martinelli, Sabina Capellari

Erschienen in: Neurological Sciences | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Familial idiopathic bilateral strio-pallido-dentate calcinosis is a rare autosomal dominant disorder characterized by massive symmetric calcification, detectable by CT, into the globus pallidus and striatum, with or without the involvement of the dentate nucleus, thalamus and white matter in the absence of alterations of calcium metabolism. Clinically, it has been associated with movement and/or neuropsychiatric disorders with age at onset typically in the fourth or fifth decade. Other sporadic or familial diseases can be responsible for brain calcifications with a similar anatomic strio-pallidal or strio-pallido-dentate pattern and, a restricted number of them, for neurological symptoms with onset in adulthood. Moreover, physiological age-related basal ganglia calcifications are often incidentally found, although with a far different CT aspect, in elderly patients with movement disorders. Indentifying familial and idiopathic cases may offer the opportunity to study the molecular mechanisms underlying this minerals deposition.
Literatur
5.
Zurück zum Zitat Lhatoo SD, Perunovic B, Love S, Houlden H, Campbell MJ (2003) Familial idiopathic brain calcification—a new and familial alpha-synucleinopathy? Eur Neurol 49(4):223–226. doi:10.1159/000070189 PubMedCrossRef Lhatoo SD, Perunovic B, Love S, Houlden H, Campbell MJ (2003) Familial idiopathic brain calcification—a new and familial alpha-synucleinopathy? Eur Neurol 49(4):223–226. doi:10.​1159/​000070189 PubMedCrossRef
6.
Zurück zum Zitat Manyam BV, Walters AS, Narla KR (2001) Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 16(2):258–264PubMedCrossRef Manyam BV, Walters AS, Narla KR (2001) Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 16(2):258–264PubMedCrossRef
8.
Zurück zum Zitat Geschwind DH, Loginov M, Stern JM (1999) Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 65(3):764–772. doi:10.1086/302558 PubMedCrossRef Geschwind DH, Loginov M, Stern JM (1999) Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 65(3):764–772. doi:10.​1086/​302558 PubMedCrossRef
9.
Zurück zum Zitat Oliveira JR, Spiteri E, Sobrido MJ, Hopfer S, Klepper J, Voit T, Gilbert J, Wszolek ZK, Calne DB, Stoessl AJ, Hutton M, Manyam BV, Boller F, Baquero M, Geschwind DH (2004) Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology 63(11):2165–2167PubMed Oliveira JR, Spiteri E, Sobrido MJ, Hopfer S, Klepper J, Voit T, Gilbert J, Wszolek ZK, Calne DB, Stoessl AJ, Hutton M, Manyam BV, Boller F, Baquero M, Geschwind DH (2004) Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology 63(11):2165–2167PubMed
10.
Zurück zum Zitat Brodaty H, Mitchell P, Luscombe G, Kwok JJ, Badenhop RF, McKenzie R, Schofield PR (2002) Familial idiopathic basal ganglia calcification (Fahr’s disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet 110(1):8–14. doi:10.1007/s00439-001-0650-x PubMedCrossRef Brodaty H, Mitchell P, Luscombe G, Kwok JJ, Badenhop RF, McKenzie R, Schofield PR (2002) Familial idiopathic basal ganglia calcification (Fahr’s disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet 110(1):8–14. doi:10.​1007/​s00439-001-0650-x PubMedCrossRef
11.
Zurück zum Zitat Sobrido MJ, Geschwind DH (2002) Genetics of familial idiopathic basal ganglia calcification (FIBGC). In: Pulst SM (ed) Genetics of movement disorders. Academic Press, San Diego, pp 443–448 Sobrido MJ, Geschwind DH (2002) Genetics of familial idiopathic basal ganglia calcification (FIBGC). In: Pulst SM (ed) Genetics of movement disorders. Academic Press, San Diego, pp 443–448
12.
Zurück zum Zitat Oliveira JR, Sobrido MJ, Spiteri E, Hopfer S, Meroni G, Petek E, Baquero M, Geschwind DH (2007) Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification (“Fahr’s disease”). J Mol Neurosci 33(2):151–154PubMedCrossRef Oliveira JR, Sobrido MJ, Spiteri E, Hopfer S, Meroni G, Petek E, Baquero M, Geschwind DH (2007) Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification (“Fahr’s disease”). J Mol Neurosci 33(2):151–154PubMedCrossRef
13.
Zurück zum Zitat Volpato CB, De Grandi A, Buffone E, Facheris M, Gebert U, Schifferle G, Schönhuber R, Hicks A, Pramstaller PP (2009) 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci 39(3):346–353. doi:10.1007/s12031-009-9287-3 PubMedCrossRef Volpato CB, De Grandi A, Buffone E, Facheris M, Gebert U, Schifferle G, Schönhuber R, Hicks A, Pramstaller PP (2009) 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci 39(3):346–353. doi:10.​1007/​s12031-009-9287-3 PubMedCrossRef
14.
Zurück zum Zitat Dai X, Gao Y, Xu Z, Cui X, Liu J, Li Y, Xu H, Liu M, Wang QK, Liu JY (2010) Identification of a novel genetic locus on chromosome 8p21.1–q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet 153B(7):1305–1310PubMedCrossRef Dai X, Gao Y, Xu Z, Cui X, Liu J, Li Y, Xu H, Liu M, Wang QK, Liu JY (2010) Identification of a novel genetic locus on chromosome 8p21.1–q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet 153B(7):1305–1310PubMedCrossRef
16.
Zurück zum Zitat Deepak S, Jayakumar B, Shanavas (2005) Extensive intracranial calcification. J Assoc Physicians India 53:948 Deepak S, Jayakumar B, Shanavas (2005) Extensive intracranial calcification. J Assoc Physicians India 53:948
17.
Zurück zum Zitat Kieffer SA, Gold LH (1974) Intracranial physiologic calcifications. Semin Roentgenol 9(2):151–162PubMedCrossRef Kieffer SA, Gold LH (1974) Intracranial physiologic calcifications. Semin Roentgenol 9(2):151–162PubMedCrossRef
18.
Zurück zum Zitat Daghighi MH, Rezaei V, Zarrintan S, Pourfathi H (2007) Intracranial physiological calcifications in adults on computed tomography in Tabriz, Iran. Folia Morphol (Warsz) 66(2):115–9 Daghighi MH, Rezaei V, Zarrintan S, Pourfathi H (2007) Intracranial physiological calcifications in adults on computed tomography in Tabriz, Iran. Folia Morphol (Warsz) 66(2):115–9
19.
Zurück zum Zitat Bosworth M, Mouw D, Skolnik DC, Hoekzema G (2008) Clinical inquiries: what is the best workup for hypocalcemia? J Fam Pract 57(10):677–679PubMed Bosworth M, Mouw D, Skolnik DC, Hoekzema G (2008) Clinical inquiries: what is the best workup for hypocalcemia? J Fam Pract 57(10):677–679PubMed
21.
Zurück zum Zitat Manabe Y, Araki M, Takeda K, Yokota S, Kimura T (1989) Pseudohypoparathyroidism with striopallidodentate calcification—a case report and review of the literature. Jpn J Med 28(3):391–395PubMed Manabe Y, Araki M, Takeda K, Yokota S, Kimura T (1989) Pseudohypoparathyroidism with striopallidodentate calcification—a case report and review of the literature. Jpn J Med 28(3):391–395PubMed
22.
23.
Zurück zum Zitat Sieberer M, Haltenhof H, Haubitz B, Pabst B, Miller K, Garlipp P (2005) Basal ganglia calcification and psychosis in 22q11.2 deletion syndrome. Eur Psychiatry 20(8):567–9 Sieberer M, Haltenhof H, Haubitz B, Pabst B, Miller K, Garlipp P (2005) Basal ganglia calcification and psychosis in 22q11.2 deletion syndrome. Eur Psychiatry 20(8):567–9
24.
Zurück zum Zitat Nordstrom DM, West SG, Andersen PA (1985) Basal ganglia calcifications in central nervous system lupus erythematosus. Arthritis Rheum 28(12):1412–1416PubMedCrossRef Nordstrom DM, West SG, Andersen PA (1985) Basal ganglia calcifications in central nervous system lupus erythematosus. Arthritis Rheum 28(12):1412–1416PubMedCrossRef
25.
Zurück zum Zitat García Raya P, Gil Aguado A, Simón Merlo MJ, Lavilla Uriol P, Vega Astudillo A, García Puig J (1994) Massive cerebral calcification in systemic lupus erythematosus: report of an unusual case. Lupus 3(2):133–135PubMedCrossRef García Raya P, Gil Aguado A, Simón Merlo MJ, Lavilla Uriol P, Vega Astudillo A, García Puig J (1994) Massive cerebral calcification in systemic lupus erythematosus: report of an unusual case. Lupus 3(2):133–135PubMedCrossRef
26.
Zurück zum Zitat Raymond AA, Zariah AA, Samad SA, Chin CN, Kong NC (1996) Brain calcification in patients with cerebral lupus. Lupus 5(2):123–128PubMedCrossRef Raymond AA, Zariah AA, Samad SA, Chin CN, Kong NC (1996) Brain calcification in patients with cerebral lupus. Lupus 5(2):123–128PubMedCrossRef
31.
32.
Zurück zum Zitat Kuroda S, Shomori A, Tateishi J (1976) Atypical Alzheimer’s disease—an autopsy case. No To Shinkei 28(4):389–395 JapanesePubMed Kuroda S, Shomori A, Tateishi J (1976) Atypical Alzheimer’s disease—an autopsy case. No To Shinkei 28(4):389–395 JapanesePubMed
33.
Zurück zum Zitat Shibayama H, Kobayashi H, Nakagawa M, Yamada K, Iwata H, Iwai K, Takeuchi T, Mu-Qune X, Ishihara R, Iwase S et al (1992) Non-Alzheimer non-Pick dementia with Fahr’s syndrome. Clin Neuropathol 11(5):237–250PubMed Shibayama H, Kobayashi H, Nakagawa M, Yamada K, Iwata H, Iwai K, Takeuchi T, Mu-Qune X, Ishihara R, Iwase S et al (1992) Non-Alzheimer non-Pick dementia with Fahr’s syndrome. Clin Neuropathol 11(5):237–250PubMed
35.
Zurück zum Zitat Jellinger KA, Bancher C (1998) Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 8(2):367–376PubMedCrossRef Jellinger KA, Bancher C (1998) Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 8(2):367–376PubMedCrossRef
36.
Zurück zum Zitat Tanabe Y, Ishizu H, Ishiguro K, Itoh N, Terada S, Haraguchi T, Kawai K, Kuroda S (2000) Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation. Neuroreport 11(11):2473–2477PubMedCrossRef Tanabe Y, Ishizu H, Ishiguro K, Itoh N, Terada S, Haraguchi T, Kawai K, Kuroda S (2000) Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation. Neuroreport 11(11):2473–2477PubMedCrossRef
37.
Zurück zum Zitat Terada S, Ishizu H, Tanabe Y, Takehisa Y, Haraguchi T, Hamaya K, Nose S, Sudo K, Kuroda S (2001) Plaque-like structures and arteriosclerotic changes in “diffuse neurofibrillary tangles with calcification” (DNTC). Acta Neuropathol 102(6):597–603PubMed Terada S, Ishizu H, Tanabe Y, Takehisa Y, Haraguchi T, Hamaya K, Nose S, Sudo K, Kuroda S (2001) Plaque-like structures and arteriosclerotic changes in “diffuse neurofibrillary tangles with calcification” (DNTC). Acta Neuropathol 102(6):597–603PubMed
39.
Zurück zum Zitat Haraguchi T, Ishizu H, Takehisa Y, Kawai K, Yokota O, Terada S, Tsuchiya K, Ikeda K, Morita K, Horike T, Kira S, Kuroda S (2001) Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity. Neuroreport 12(18):3887–90. Erratum in: Neuroreport 2002 13(1):inside back cover Haraguchi T, Ishizu H, Takehisa Y, Kawai K, Yokota O, Terada S, Tsuchiya K, Ikeda K, Morita K, Horike T, Kira S, Kuroda S (2001) Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity. Neuroreport 12(18):3887–90. Erratum in: Neuroreport 2002 13(1):inside back cover
40.
Zurück zum Zitat Tonge JI, Burry AF, Saal JR (1977) Cerebellar calcification: a possible marker of lead poisoning. Pathology 9:289–300PubMedCrossRef Tonge JI, Burry AF, Saal JR (1977) Cerebellar calcification: a possible marker of lead poisoning. Pathology 9:289–300PubMedCrossRef
41.
Zurück zum Zitat Benson MD, Price J (1985) Cerebellar calcification and lead. J Neurol Neurosurg Psychiatry 48:814–818PubMedCrossRef Benson MD, Price J (1985) Cerebellar calcification and lead. J Neurol Neurosurg Psychiatry 48:814–818PubMedCrossRef
42.
Zurück zum Zitat Reyes PF, Gonzalez CF, Zalewska MK, Besarab A (1986) Intracranial calcification in adults with chronic lead exposure. Am J Roentgenol 146:267–270 Reyes PF, Gonzalez CF, Zalewska MK, Besarab A (1986) Intracranial calcification in adults with chronic lead exposure. Am J Roentgenol 146:267–270
43.
Zurück zum Zitat Thomas KP, Muthugovindan D, Singer HS (2010) Paroxysmal kinesigenic dyskinesias and pseudohypo-parathyroidism type Ib. Pediatr Neurol 43(1):61–64PubMedCrossRef Thomas KP, Muthugovindan D, Singer HS (2010) Paroxysmal kinesigenic dyskinesias and pseudohypo-parathyroidism type Ib. Pediatr Neurol 43(1):61–64PubMedCrossRef
44.
Zurück zum Zitat Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN (2010) Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia. Pediatr Neurol 43(1):46–48PubMedCrossRef Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN (2010) Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia. Pediatr Neurol 43(1):46–48PubMedCrossRef
45.
Zurück zum Zitat Alemdar M, Iseri P, Selekler M, Komsuoğlu SS (2007) Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia. Clin Neuropharmacol 30(4):241–244 PubMed PMID: 17762321PubMed Alemdar M, Iseri P, Selekler M, Komsuoğlu SS (2007) Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia. Clin Neuropharmacol 30(4):241–244 PubMed PMID: 17762321PubMed
46.
Zurück zum Zitat Harwood-Nash DC, Reilly BJ (1970) Calcification of the basal ganglia following radiation therapy. Am J Roentgenol Radium Ther Nucl Med 108(2):392–395PubMed Harwood-Nash DC, Reilly BJ (1970) Calcification of the basal ganglia following radiation therapy. Am J Roentgenol Radium Ther Nucl Med 108(2):392–395PubMed
47.
Zurück zum Zitat Williams JP, Dixon G, Fowler GW, Pribram HF, Sargent EN, Turner AF (1973) Calcification of the auricular cartilage and basal ganglia secondary to radiation therapy. Bull Los Angeles Neurol Soc 38(1):33–36PubMed Williams JP, Dixon G, Fowler GW, Pribram HF, Sargent EN, Turner AF (1973) Calcification of the auricular cartilage and basal ganglia secondary to radiation therapy. Bull Los Angeles Neurol Soc 38(1):33–36PubMed
48.
Zurück zum Zitat Numaguchi Y, Hoffman JC, Sones PJ (1975) Basal ganglia calcification as a late radiation effect. Am J RoentgenolRadium Ther Nucl Med 123(1):27–30 Numaguchi Y, Hoffman JC, Sones PJ (1975) Basal ganglia calcification as a late radiation effect. Am J RoentgenolRadium Ther Nucl Med 123(1):27–30
49.
Zurück zum Zitat Illum F (1980) Calcification of the basal ganglia following carbon monoxide poisoning. Neuroradiology 19:213–214PubMedCrossRef Illum F (1980) Calcification of the basal ganglia following carbon monoxide poisoning. Neuroradiology 19:213–214PubMedCrossRef
50.
Zurück zum Zitat Smith D, Bloch S, Al-Rashid RA (1980) Basal ganglia calcification on CT scanning in children with acute lymphocytic leukemia. Neuroradiology 20(2):91–93PubMedCrossRef Smith D, Bloch S, Al-Rashid RA (1980) Basal ganglia calcification on CT scanning in children with acute lymphocytic leukemia. Neuroradiology 20(2):91–93PubMedCrossRef
51.
Zurück zum Zitat Almubarak S, Gan YC, Steinbok P, Hendson G, Poskitt K, Nadel H, Goddard K, Hukin J (2009) Occurrence of basal ganglia germ cell tumors without a mass. Arch Neurol 66(6):789–787 doi:10.1001/archneurol.2009.74 Almubarak S, Gan YC, Steinbok P, Hendson G, Poskitt K, Nadel H, Goddard K, Hukin J (2009) Occurrence of basal ganglia germ cell tumors without a mass. Arch Neurol 66(6):789–787 doi:10.​1001/​archneurol.​2009.​74
52.
Zurück zum Zitat Hakola HP (1972) Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl 232:1–173PubMed Hakola HP (1972) Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl 232:1–173PubMed
53.
Zurück zum Zitat Nasu T, Tsukahara Y, Terayama K (1973) A lipid metabolic disease-”membranouslipodystrophy”—an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol Jpn 23(3):539–558PubMed Nasu T, Tsukahara Y, Terayama K (1973) A lipid metabolic disease-”membranouslipodystrophy”—an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol Jpn 23(3):539–558PubMed
55.
Zurück zum Zitat Matsuo T, Suetsugu M, Eguchi M, Sasaki M, Tsuneyoshi M (1982) Membranous lipodystrophy. A case report. Arch Psychiatr Nervenkr 231(2):123–130PubMedCrossRef Matsuo T, Suetsugu M, Eguchi M, Sasaki M, Tsuneyoshi M (1982) Membranous lipodystrophy. A case report. Arch Psychiatr Nervenkr 231(2):123–130PubMedCrossRef
56.
Zurück zum Zitat Hakola HP, Puranen M (1993) Neuropsychiatric and brain CT findings in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Acta Neurol Scand 88(5):370–375PubMedCrossRef Hakola HP, Puranen M (1993) Neuropsychiatric and brain CT findings in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Acta Neurol Scand 88(5):370–375PubMedCrossRef
57.
Zurück zum Zitat Iivanainen M, Hakola P, Erkinjuntti T, Sipponen JT, Ketonen L, Sulkava R, Sepponen RE (1984) Cerebral MR and CT imaging in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. J Comput Assist Tomogr 8(5):940–943PubMedCrossRef Iivanainen M, Hakola P, Erkinjuntti T, Sipponen JT, Ketonen L, Sulkava R, Sepponen RE (1984) Cerebral MR and CT imaging in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. J Comput Assist Tomogr 8(5):940–943PubMedCrossRef
58.
Zurück zum Zitat Markesbery WR (1979) Lactic acidemia, mitochondrial myopathy, and basal ganglia calcification. Neurology 29(7):1057–1060PubMed Markesbery WR (1979) Lactic acidemia, mitochondrial myopathy, and basal ganglia calcification. Neurology 29(7):1057–1060PubMed
59.
Zurück zum Zitat Hirano M, Pavlakis SG (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 9(1):4–13PubMedCrossRef Hirano M, Pavlakis SG (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 9(1):4–13PubMedCrossRef
60.
Zurück zum Zitat Younes-Mhenni S, Thobois S, Streichenberger N, Giraud P, Mousson-de-Camaret B, Montelescaut ME et al (2002) Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) associated with a Fahr disease and cerebellar calcifications. Rev Med Interne 23:1027–1029PubMedCrossRef Younes-Mhenni S, Thobois S, Streichenberger N, Giraud P, Mousson-de-Camaret B, Montelescaut ME et al (2002) Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) associated with a Fahr disease and cerebellar calcifications. Rev Med Interne 23:1027–1029PubMedCrossRef
62.
Zurück zum Zitat Nakamura M, Nakano S, Goto Y, Ozawa M, Nagahama Y, Fukuyama H, Akiguchi I, Kaji R, Kimura J (1995) A novel point mutation in the mitochondrial tRNA (Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 214(1):86–93. doi:10.1006/bbrc.1995.2260 PubMedCrossRef Nakamura M, Nakano S, Goto Y, Ozawa M, Nagahama Y, Fukuyama H, Akiguchi I, Kaji R, Kimura J (1995) A novel point mutation in the mitochondrial tRNA (Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 214(1):86–93. doi:10.​1006/​bbrc.​1995.​2260 PubMedCrossRef
64.
Zurück zum Zitat Bataillard M, Chatzoglou E, Rumbach L, Sternberg D, Tournade A, Laforêt P, Jardel C, Maisonobe T, Lombès A (2001) Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 56(3):405–407PubMed Bataillard M, Chatzoglou E, Rumbach L, Sternberg D, Tournade A, Laforêt P, Jardel C, Maisonobe T, Lombès A (2001) Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 56(3):405–407PubMed
65.
Zurück zum Zitat Mariotti C, Savarese N, Suomalainen A, Rimoldi M, Comi G, Prelle A, Antozzi C, Servidei S, Jarre L, DiDonato S, Zeviani M (1995) Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 242(5):304–312PubMedCrossRef Mariotti C, Savarese N, Suomalainen A, Rimoldi M, Comi G, Prelle A, Antozzi C, Servidei S, Jarre L, DiDonato S, Zeviani M (1995) Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 242(5):304–312PubMedCrossRef
66.
Zurück zum Zitat Martinelli P, Giuliani S, Ippoliti M, Martinelli A, Sforza A, Ferrari S (1993) Familial idiopathic strio-pallidodentate calcifications with late onset extrapyramidal syndrome. Mov Disord 8(2):220–2. doi:10.1002/mds.870080221 Martinelli P, Giuliani S, Ippoliti M, Martinelli A, Sforza A, Ferrari S (1993) Familial idiopathic strio-pallidodentate calcifications with late onset extrapyramidal syndrome. Mov Disord 8(2):220–2. doi:10.​1002/​mds.​870080221
Metadaten
Titel
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients
verfasst von
Sara Bonazza
Chiara La Morgia
Paolo Martinelli
Sabina Capellari
Publikationsdatum
01.08.2011
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 4/2011
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0514-7

Weitere Artikel der Ausgabe 4/2011

Neurological Sciences 4/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.